April 9, 2025-April 10, 2025 2025 Clinical Outcome Assessment Program Annual Meeting On April 9-10, 2025, the 2025 Clinical Outcome Assessment...
December 13, 2024 Real-world evidence in the cloud: Tutorial on developing an end-to-end data and analytics pipeline using Amazon Web Services resources In the rapidly evolving landscape of healthcare and drug development, the ability to efficiently collect...
December 12, 2024 The Power of Data Sharing and Collaboration Across LGMDs in a Pre-competitive, Neutral Environment This event featured Dr. Volker Straub, a renowned neuromuscular genetics expert...
December 10, 2024 Biomarkers 101: A Patient’s Perspective on the Importance of Identifying New Biomarkers Biomarkers are emerging as powerful tools in the field of kidney health, playing a crucial role in the diagnosis, monitoring...
November 27, 2024 C-Path’s Romero, Swingle Named to 100 Most Innovative and Influential Healthcare Leaders in AZ Big Media C-Path CEO Klaus Romero and President & COO Kristen Swingle, President and COO were recently named to the 100 Most...
November 27, 2024 A computational tool to optimize clinical trial parameter selection in Duchenne muscular dystrophy: A practical guide and case studies Duchenne muscular dystrophy (DMD), a rare pediatric disease, presents numerous challenges when designing clinical trials...
November 27, 2024 Autosomal Recessive Polycystic Kidney Disease (ARPKD)Adjunct EL-PFDD Scientific Workshop Report The mission of the Polycystic Kidney Disease Foundation is to fund research, advocate for patients, and ultimately to end PKD..
November 27, 2024 Voice of the Patient report Externally-Led Patient-Focused Drug Development (EL-PFDD) Meeting for ARPKD Patients and their Families Autosomal Recessive Polycystic Kidney Disease (ARPKD) is a rare genetic disease. It occurs in about one in 20,000 births...
November 19, 2024 C-Path’s TRxA Announces $1 Million Award for Drug Development Project in Type 1 Diabetes TUCSON, Ariz., November 19, 2024 — Critical Path Institute® (C-Path) today announced that its Translational Therapeutics Accele
November 17, 2024 Advancing Neonatal Drug Development: Celebrating Progress on World Prematurity Day On this occasion of World Prematurity Awareness Day, we reflect on the immense progress we have made together and recognize...
